Immune responses to a GnRH-based anti-fertility immunogen, induced by different adjuvants and subsequent effect on vaccine efficacy

Ferro, V.A. and Costa, R. and Carter, K.C. and Harvey, M.J. and Waterston, M.M. and Mullen, A. and Matschke, C. and Mann, J.F.S. and Colston, A. and Stimson, W.H. (2004) Immune responses to a GnRH-based anti-fertility immunogen, induced by different adjuvants and subsequent effect on vaccine efficacy. Vaccine, 22 (8). pp. 1024-31. ISSN 1873-2518 (https://doi.org/10.1016/j.vaccine.2003.08.043)

Full text not available in this repository.Request a copy

Abstract

A modified GnRH peptide (CHWSYGLRPG-NH2) was conjugated to tetanus toxoid and formulated with different adjuvants (non-ionic surfactant vesicles, aluminium hydroxide, Quil A, PLGA (poly(lactide-co-glycolide)/triacetin), and Quil A/PLGA). A comparison of the anti-fertility efficacy of the formulations was made by examining specific antibody levels, antibody subclasses, endocrine ablation and gonadal atrophy. The production of IgG2b antibody provided the best correlation for castration. PLGA was considered the most effective adjuvant as it produced a consistent anti-fertility response in all the treated animals.

CORE (COnnecting REpositories)